AllianceBernstein’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-324,702
Closed -$25.9M 3516
2021
Q1
$25.9M Buy
324,702
+226,907
+232% +$17.7M 0.01% 842
2020
Q4
$7.71M Sell
97,795
-880
-0.9% -$51.6K ﹤0.01% 1257
2020
Q3
$4.34M Sell
98,675
-1,870
-2% -$92.1K ﹤0.01% 1408
2020
Q2
$4.45M Buy
100,545
+37,490
+59% +$1.4M ﹤0.01% 1388
2020
Q1
$2.26M Sell
63,055
-180
-0.3% -$10.2K ﹤0.01% 1607
2019
Q4
$4.48M Buy
63,235
+1,820
+3% +$132K ﹤0.01% 1496
2019
Q3
$4.59M Sell
61,415
-625
-1% -$53K ﹤0.01% 1434
2019
Q2
$5M Sell
62,040
-13,540
-18% -$952K ﹤0.01% 1416
2019
Q1
$5.06M Sell
75,580
-190
-0.3% -$14.4K ﹤0.01% 1376
2018
Q4
$5.64M Buy
75,770
+40,660
+116% +$3.36M ﹤0.01% 1240
2018
Q3
$3.23M Sell
35,110
-15,170
-30% -$1.44M ﹤0.01% 1593
2018
Q2
$4.95M Sell
50,280
-32,480
-39% -$3.63M ﹤0.01% 1250
2018
Q1
$9.22M Buy
82,760
+25,680
+45% +$2.88M 0.01% 971
2017
Q4
$5.87M Sell
57,080
-4,150
-7% -$413K ﹤0.01% 1141
2017
Q3
$5.77M Hold
61,230
﹤0.01% 1144
2017
Q2
$4.77M Buy
61,230
+6,850
+13% +$514K ﹤0.01% 1238
2017
Q1
$4.36M Sell
54,380
-1,013
-2% -$80.5K ﹤0.01% 1268
2016
Q4
$4.36M Sell
55,393
-1,400
-2% -$109K ﹤0.01% 1275
2016
Q3
$4.43M Sell
56,793
-17,677
-24% -$1.28M ﹤0.01% 1181
2016
Q2
$5.12M Buy
74,470
+15,566
+26% +$1.07M ﹤0.01% 1066
2016
Q1
$4.2M Sell
58,904
-5,976
-9% -$375K ﹤0.01% 1129
2015
Q4
$4.03M Sell
64,880
-6,319
-9% -$385K ﹤0.01% 1155
2015
Q3
$4.04M Sell
71,199
-51
-0.1% -$2.7K ﹤0.01% 1158
2015
Q2
$3.82M Hold
71,250
﹤0.01% 1271
2015
Q1
$3.38M Hold
71,250
﹤0.01% 1364
2014
Q4
$3.08M Hold
71,250
﹤0.01% 1419
2014
Q3
$2.45M Hold
71,250
﹤0.01% 1557
2014
Q2
$2.61M Buy
71,250
+12,597
+21% +$427K ﹤0.01% 1580
2014
Q1
$1.98M Buy
58,653
+87
+0.1% +$2.87K ﹤0.01% 1725
2013
Q4
$1.99M Sell
58,566
-204
-0.3% -$7.07K ﹤0.01% 1706
2013
Q3
$1.87M Buy
58,770
+1,188
+2% +$31.6K ﹤0.01% 1720
2013
Q2
$1.3M Buy
+57,582
New +$1.25M ﹤0.01% 1920

AllianceBernstein's CMD Position: Q2 2021 in Review

AllianceBernstein sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 324,702 shares — an estimated $25.9M sold.

AllianceBernstein first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $25.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • AllianceBernstein reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • AllianceBernstein sold 324,702 Cantel Medical Corporation shares in Q2 2021, an estimated $25.9M.
  • AllianceBernstein first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
  • AllianceBernstein's Cantel Medical Corporation position peaked at $25.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.